NIFFENEGGER KATHI 4
4 · Edesa Biotech, Inc. · Filed Feb 14, 2020
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2020-02-12+88,699→ 88,699 totalExercise: $3.16Exp: 2030-02-12→ Common Shares (88,699 underlying)
Footnotes (1)
- [F1]33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested